Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis: The NEOSII Score

NCT06023160 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06023160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06023160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis: The NEOSII Score
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
July 1, 2024
Enrollment
714 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anti-nmda (n-methyl d-aspartate) receptor encephalitis